Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Estimates Dollar Costs For Adverse Event Labeling But Doubts Persist

This article was originally published in The Tan Sheet

Executive Summary

FDA's estimate of nearly $44 million for the dietary supplement industry to revise labels to comply with the adverse event reporting law may understate the actual burden by leaving out some key costs
Advertisement

Related Content

Final AER Guidance Requires Full Address, Recommends Prefatory Language
Final AER Guidance Requires Full Address, Recommends Prefatory Language
FDA Lacks Legal Sway To Enforce AER Label Revisions – Attorney
FDA Lacks Legal Sway To Enforce AER Label Revisions – Attorney
AER Label Guidance Holds To Requiring Full Addresses For OTCs, Supplements
NPA expects AER cost estimates
SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
Return To Sender, Industry Groups Say Of AER Address Guidance
Advertisement
UsernamePublicRestriction

Register

PS102655

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel